Latest news:
Sign up for our Newsletter

Follicum’s compliance with GDPR. Read more

Hair growth

Our drug candidate FOL-005 has demonstrated increased hair growth on both healthy individuals and on patients with alopecia in two clinical phase II trials, which both demonstrated good safety and efficacy.

Read more


Follicums pre-clinical research has resulted in a new peptide class which increased the release of insulin on mice

Read more


We want to develop safe, effective and cost effective drugs, suitable for both men and women, that have minimal side effects

Read more




04 Feb 20
LSX World Congress

Follicum will attend the LSX World Congress in London, UK, on 4-5 February 2020 The conference...

08 Jun 20
BIO International Convention

Follicum will attend the BIO International Convention in San Diego, USA, on 8-11 June 2020 The confe...